These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 32173532

  • 1. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
    Wang J, Zhang X, Yang C, Zhao S.
    Biochem Biophys Res Commun; 2020 May 14; 525(4):962-967. PubMed ID: 32173532
    [Abstract] [Full Text] [Related]

  • 2. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
    Costola-de-Souza C, Ribeiro A, Ferraz-de-Paula V, Calefi AS, Aloia TP, Gimenes-Júnior JA, de Almeida VI, Pinheiro ML, Palermo-Neto J.
    PLoS One; 2013 May 14; 8(10):e77706. PubMed ID: 24204926
    [Abstract] [Full Text] [Related]

  • 3. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
    Kerr DM, Harhen B, Okine BN, Egan LJ, Finn DP, Roche M.
    Br J Pharmacol; 2013 Jun 14; 169(4):808-19. PubMed ID: 23043675
    [Abstract] [Full Text] [Related]

  • 4. The role of CB1 in intestinal permeability and inflammation.
    Karwad MA, Couch DG, Theophilidou E, Sarmad S, Barrett DA, Larvin M, Wright KL, Lund JN, O'Sullivan SE.
    FASEB J; 2017 Aug 14; 31(8):3267-3277. PubMed ID: 28404744
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P, Petrella C, Forti F, Passeri PP, Morena M, Palmery M, Trezza V, Severini C, Campolongo P.
    Neuropharmacology; 2018 Aug 14; 138():210-218. PubMed ID: 29842858
    [Abstract] [Full Text] [Related]

  • 6. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.
    Woodhams SG, Wong A, Barrett DA, Bennett AJ, Chapman V, Alexander SP.
    Br J Pharmacol; 2012 Dec 14; 167(8):1609-19. PubMed ID: 22924700
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A, Okine BN, Finn DP, Masocha W.
    Biomed Pharmacother; 2020 Sep 14; 129():110456. PubMed ID: 32603895
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
    Alhouayek M, Lambert DM, Delzenne NM, Cani PD, Muccioli GG.
    FASEB J; 2011 Aug 14; 25(8):2711-21. PubMed ID: 21551239
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
    Sciolino NR, Zhou W, Hohmann AG.
    Pharmacol Res; 2011 Sep 14; 64(3):226-34. PubMed ID: 21600985
    [Abstract] [Full Text] [Related]

  • 12. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG, Wise LE, Ramesh D, Abdullah R, Selley DE, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2013 Jun 14; 345(3):492-501. PubMed ID: 23412396
    [Abstract] [Full Text] [Related]

  • 13. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
    Khasabova IA, Yao X, Paz J, Lewandowski CT, Lindberg AE, Coicou L, Burlakova N, Simone DA, Seybold VS.
    Pharmacol Res; 2014 Dec 14; 90():67-75. PubMed ID: 25304184
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
    Limebeer CL, Abdullah RA, Rock EM, Imhof E, Wang K, Lichtman AH, Parker LA.
    Psychopharmacology (Berl); 2014 Feb 14; 231(3):603-12. PubMed ID: 24043345
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 14; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 16. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
    Gomez O, Arevalo-Martin A, Garcia-Ovejero D, Ortega-Gutierrez S, Cisneros JA, Almazan G, Sánchez-Rodriguez MA, Molina-Holgado F, Molina-Holgado E.
    Glia; 2010 Dec 14; 58(16):1913-27. PubMed ID: 20878765
    [Abstract] [Full Text] [Related]

  • 17. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
    Miller S, Leishman E, Hu SS, Elghouche A, Daily L, Murataeva N, Bradshaw H, Straiker A.
    Invest Ophthalmol Vis Sci; 2016 Jun 01; 57(7):3287-96. PubMed ID: 27333182
    [Abstract] [Full Text] [Related]

  • 18. Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase.
    Liu X, Chen Y, Vickstrom CR, Li Y, Viader A, Cravatt BF, Liu QS.
    Sci Rep; 2016 Oct 24; 6():35829. PubMed ID: 27775008
    [Abstract] [Full Text] [Related]

  • 19. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF.
    Nat Chem Biol; 2009 Jan 24; 5(1):37-44. PubMed ID: 19029917
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
    Aymerich MS, Rojo-Bustamante E, Molina C, Celorrio M, Sánchez-Arias JA, Franco R.
    Mol Neurobiol; 2016 May 24; 53(4):2312-9. PubMed ID: 25976369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.